Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-03-04 Sale | 2024-03-06 6:19 pm | Atara Biotherapeutics Inc. | ATRA | Touchon Pascal President and CEO | 24,844 | $0.72 | $17,888 | 1,910,652 (Direct) | View |
2024-03-04 Sale | 2024-03-06 6:18 pm | Atara Biotherapeutics Inc. | ATRA | Nguyen AnhCo EVP, Chief Sci. & Tech Officer | 10,746 | $0.72 | $7,737 | 941,397 (Direct) | View |
2024-03-04 Sale | 2024-03-06 6:18 pm | Atara Biotherapeutics Inc. | ATRA | Murugan Amar EVP, Chief Legal Officer | 10,044 | $0.72 | $7,232 | 727,521 (Direct) | View |
2024-03-04 Sale | 2024-03-06 6:17 pm | Atara Biotherapeutics Inc. | ATRA | Hyllengren Eric J EVP, CFO | 6,679 | $0.72022 | $4,810 | 674,319 (Direct) | View |
2024-03-04 Sale | 2024-03-06 6:16 pm | Atara Biotherapeutics Inc. | ATRA | Henrich Jill EVP, Global Head RA & Quality | 3,879 | $0.72 | $2,793 | 555,001 (Direct) | View |
2023-11-16 Sale | 2023-11-20 5:31 pm | Atara Biotherapeutics Inc. | ATRA | Touchon Pascal President and CEO | 20,409 | $0.389 | $7,939 | 655,496 (Direct) | View |
2023-11-16 Sale | 2023-11-20 5:31 pm | Atara Biotherapeutics Inc. | ATRA | Nguyen AnhCo EVP, Chief Sci. & Tech Officer | 8,856 | $0.389 | $3,445 | 277,143 (Direct) | View |
2023-11-16 Sale | 2023-11-20 5:30 pm | Atara Biotherapeutics Inc. | ATRA | Murugan Amar EVP, Chief Legal Officer | 8,307 | $0.389 | $3,231 | 257,084 (Direct) | View |
2023-11-16 Sale | 2023-11-20 5:30 pm | Atara Biotherapeutics Inc. | ATRA | Joshi Manher EVP, Chief Medical Officer | 12,287 | $0.389 | $4,780 | 171,284 (Direct) | View |
2023-11-16 Sale | 2023-11-20 5:29 pm | Atara Biotherapeutics Inc. | ATRA | Hyllengren Eric J SVP, CFO | 11,958 | $0.389 | $4,652 | 205,998 (Direct) | View |
2023-11-16 Sale | 2023-11-20 5:29 pm | Atara Biotherapeutics Inc. | ATRA | Henrich Jill EVP, Global Head RA & Quality | 3,267 | $0.389 | $1,271 | 104,424 (Direct) | View |
2023-11-13 Purchase | 2023-11-15 5:07 pm | Atara Biotherapeutics Inc. | ATRA | Gallagher Carol Giltner Director | 270,000 | $0.25265 | $68,214 | 459,418 (Direct) | View |
2023-11-10 Purchase | 2023-11-14 6:29 pm | Atara Biotherapeutics Inc. | ATRA | HEIDEN WILLIAM K Director | 100,000 | $0.2533 | $25,330 | 209,000 (Direct) | View |
2023-11-10 Purchase | 2023-11-14 6:27 pm | Atara Biotherapeutics Inc. | ATRA | DOBMEIER ERIC Director | 446,825 | $0.2268 | $101,340 | 563,325 (Direct) | View |
2023-08-16 Sale | 2023-08-18 6:25 pm | Atara Biotherapeutics Inc. | ATRA | Hyllengren Eric J SVP, CFO | 8,186 | $1.6524 | $13,527 | 217,956 (Direct) | View |
2023-08-16 Sale | 2023-08-18 6:25 pm | Atara Biotherapeutics Inc. | ATRA | Murugan Amar EVP, Chief Legal Officer | 8,672 | $1.6524 | $14,330 | 265,391 (Direct) | View |
2023-08-16 Sale | 2023-08-18 6:25 pm | Atara Biotherapeutics Inc. | ATRA | Touchon Pascal President and CEO | 30,766 | $1.6523 | $50,835 | 675,905 (Direct) | View |
2023-08-16 Sale | 2023-08-18 6:25 pm | Atara Biotherapeutics Inc. | ATRA | Nguyen AnhCo EVP, Chief Sci. & Tech Officer | 15,126 | $1.6526 | $24,997 | 285,999 (Direct) | View |
2023-08-16 Sale | 2023-08-18 6:25 pm | Atara Biotherapeutics Inc. | ATRA | Joshi Manher EVP, Chief Medical Officer | 6,975 | $1.6525 | $11,526 | 183,571 (Direct) | View |
2023-08-16 Sale | 2023-08-18 6:25 pm | Atara Biotherapeutics Inc. | ATRA | Henrich Jill EVP, Global Head RA & Quality | 3,346 | $1.6532 | $5,531 | 107,691 (Direct) | View |
2023-06-27 Sale | 2023-06-29 4:15 pm | Atara Biotherapeutics Inc. | ATRA | Touchon Pascal President and CEO | 14,291 | $1.66 | $23,723 | 706,671 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-03-31 Option Award | 2024-04-02 6:13 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Fust Matthew K Director | 150,000 | $0 | 259,000 (Direct) | View |
2024-03-31 Option Award | 2024-04-02 6:12 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | HEIDEN WILLIAM K Director | 150,000 | $0 | 359,000 (Direct) | View |
2024-03-31 Option Award | 2024-04-02 6:12 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Roncarolo Maria Grazia Director | 150,000 | $0 | 238,500 (Direct) | View |
2024-03-31 Option Award | 2024-04-02 6:12 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Gallagher Carol Giltner Director | 150,000 | $0 | 629,608 (Direct) | View |
2024-03-31 Option Award | 2024-04-02 6:11 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | MALLIK AMEET Director | 150,000 | $0 | 227,500 (Direct) | View |
2024-01-08 Option Award | 2024-01-09 4:41 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Touchon Pascal President and CEO | 1,280,000 | $0 | 1,935,496 (Direct) | View |
2024-01-08 Option Award | 2024-01-09 4:40 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Nguyen AnhCo EVP, Chief Sci. & Tech Officer | 675,000 | $0 | 952,143 (Direct) | View |
2024-01-08 Option Award | 2024-01-09 4:40 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Murugan Amar EVP, Chief Legal Officer | 475,000 | $0 | 737,565 (Direct) | View |
2024-01-08 Option Award | 2024-01-09 4:40 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Hyllengren Eric J EVP, CFO | 475,000 | $0 | 680,998 (Direct) | View |
2024-01-08 Option Award | 2024-01-09 4:40 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Henrich Jill EVP, Global Head RA & Quality | 450,000 | $0 | 558,880 (Direct) | View |
Ownership | 2023-06-09 4:30 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Henrich Jill EVP, Global Head RA & Quality | 0 | $0 | 353,115 (Direct) | View |
Ownership | 2023-06-09 4:30 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Nguyen AnhCo EVP, Chief Sci. & Tech Officer | 0 | $0 | 934,425 (Direct) | View |
Ownership | 2023-06-09 4:30 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Joshi Manher EVP, Chief Medical Officer | 0 | $0 | 777,052 (Direct) | View |
2023-05-31 Option Award | 2023-06-02 8:06 pm | N/A 2033-05-30 | Atara Biotherapeutics Inc. | ATRA | SEIDENBERG BETH C Director | 136,500 | $0 | 2,072,233 (Direct) | View |
2023-05-31 Option Award | 2023-06-02 7:09 pm | N/A 2033-05-30 | Atara Biotherapeutics Inc. | ATRA | Roncarolo Maria Grazia Director | 136,500 | $0 | 168,000 (Direct) | View |
2023-05-31 Option Award | 2023-06-02 7:09 pm | N/A 2033-05-30 | Atara Biotherapeutics Inc. | ATRA | Gallagher Carol Giltner Director | 136,500 | $0 | 268,918 (Direct) | View |
2023-05-31 Option Award | 2023-06-02 7:09 pm | N/A 2033-05-30 | Atara Biotherapeutics Inc. | ATRA | Fust Matthew K Director | 136,500 | $0 | 188,500 (Direct) | View |
2023-05-31 Option Award | 2023-06-02 7:09 pm | N/A 2033-05-30 | Atara Biotherapeutics Inc. | ATRA | MALLIK AMEET Director | 136,500 | $0 | 157,000 (Direct) | View |
2023-05-31 Option Award | 2023-06-02 7:09 pm | N/A 2033-05-30 | Atara Biotherapeutics Inc. | ATRA | DOBMEIER ERIC Director | 136,500 | $0 | 196,000 (Direct) | View |